Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex in Kidney and Pancreas Transplantation
NCT04944303Completed
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- Dec 2020
- Primary completion
- Apr 2021
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Recovery time of the neuromuscular blockade up to 3 months. Started Dec 2020; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT04944303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04944303.